Carlyle Group Inc.
Institutional investor · Portfolio as of Q1 2024
Top Holdings32 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
QUIDELORTHO CORP | 12.5M | $597.3M | 37.7% | $100.03 | -52.07% | 8 qtrssince 2022-Q2 | Unchanged 0 |
ZOOMINFO TECHNOLOGIES INC | 26.2M | $420.7M | 26.5% | $50.72 | -68.40% | 16 qtrssince 2020-Q2 | Decreased 0 |
SOLENO THERAPEUTICS INC | 4.1M | $173.1M | 10.9% | $26.90 | +59.08% | 5 qtrssince 2023-Q1 | Increased 80 |
VITRU LTD | 6.2M | $94M | 5.9% | — | — | 15 qtrssince 2020-Q3 | Unchanged 0 |
VERONA PHARMA PLC | 2.5M | $39.4M | 2.5% | — | — | 5 qtrssince 2023-Q1 | Unchanged 0 |
GETTY IMAGES HOLDINGS INC | 9.2M | $38.2M | 2.4% | $5.55 | -25.23% | 6 qtrssince 2022-Q4 | Decreased 0 |
PHATHOM PHARMACEUTICALS INC | 3.5M | $37.1M | 2.3% | $7.87 | +34.86% | 5 qtrssince 2023-Q1 | Unchanged 0 |
JASPER THERAPEUTICS INC | 1.1M | $31.3M | 2.0% | $18.80 | +56.17% | 5 qtrssince 2023-Q1 | Decreased 0 |
HILLEVAX INC | 1.8M | $30.5M | 1.9% | — | — | 5 qtrssince 2023-Q1 | Unchanged 0 |
GDS Holdings Ltd. Sponsored ADR Class A | 4.1M | $27.1M | 1.7% | $20.58 | -67.68% | 6 qtrssince 2022-Q4 | Unchanged 0 |
SEACOR MARINE HLDGS INC | 1.3M | $18.3M | 1.2% | $10.73 | +29.88% | 22 qtrssince 2018-Q4 | Unchanged 0 |
Q32 BIO INC | 1.1M | $18.1M | 1.1% | $17.04 | 0.00% | 1 qtr | New 66 |
INVITATION HOMES INC | 477,500 | $17M | 1.1% | $27.70 | +20.69% | 5 qtrssince 2023-Q1 | Unchanged 0 |
CUBESMART | 220,500 | $10M | 0.6% | $33.47 | +24.05% | 7 qtrssince 2022-Q3 | Unchanged 0 |
| 2.9M | $6.9M | 0.4% | — | — | 5 qtrssince 2023-Q1 | Increased 44 | |
KRISPY KREME INC | 340,748 | $5.2M | 0.3% | $14.92 | 0.00% | 1 qtr | New 46 |
| 2.7M | $4.5M | 0.3% | — | — | 5 qtrssince 2023-Q1 | Unchanged 0 | |
SMART SH GLOBAL LTD | 4.8M | $3.2M | 0.2% | $1.12 | -42.86% | 8 qtrssince 2022-Q2 | Unchanged 0 |
eFFECTOR Therapeutics, Inc. | 192,884 | $2.7M | 0.2% | — | — | — | — |
SUNPOWER INC | 4.9M | $2.7M | 0.2% | $1.39 | -56.81% | 3 qtrssince 2023-Q3 | Increased 49 |
Carlyle Group Inc. manages $1.6B across 32 positions as of Q1 2024. Top holdings: QDEL (37.7%), GTM (26.5%), SLNO (10.9%). Fund DNA: Concentrated Value. HoldingsIntel Rating: 1.5/5.0.
Active quarter - 8 new positions, 1 exits, 3 increased. Top move: SLNO (INCREASED, conviction 80). Portfolio: $1.6B across 32 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer